AJANTPHARM

Ajanta Pharma Share Price

 
Stock touched 52W high

 

Invest in Ajanta Pharma with 3.47X leverage

Invest with MTF
Ajanta Pharma live price: ₹3030.6. It opened at ₹3,137 vs previous close ₹3,120; intraday high/low: ₹3,228/₹3,007. The 50 & 200 DMA stand at ₹2,875.80/₹2,708.62.

Ajanta Pharma Performance

  • Low
  • ₹3,007
  • High
  • ₹3,228
  • 52 Week Low
  • ₹2,327
  • 52 Week High
  • ₹3,228
  • Open Price₹3,137
  • Previous Close₹3,120
  • Volume154,564
  • 50 DMA₹2,875.80
  • 100 DMA₹2,779.35
  • 200 DMA₹2,708.62

Investment Returns

  • Over 1 Month + 4.87%
  • Over 3 Month + 13.94%
  • Over 6 Month + 17.51%
  • Over 1 Year + 19.08%

Smart Investing Starts Here Start SIP with Ajanta Pharma for Steady Growth!

Invest Now

Ajanta Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 37.3
  • PEG Ratio
  • 2.9
  • Market Cap Cr
  • 37,856
  • P/B Ratio
  • 8.2
  • Average True Range
  • 94.09
  • EPS
  • 81.21
  • Dividend Yield
  • 0.9
  • MACD Signal
  • 49.36
  • RSI
  • 57.62
  • MFI
  • 59.09

Ajanta Pharma Financials

Ajanta Pharma Technicals

EMA & SMA

Current Price
₹3,030.60
-88.9 (-2.85%)
pointer
  • Bearish Moving Average 1
  • Bullish Moving Average 15
  • 20 Day
  • ₹2,972.15
  • 50 Day
  • ₹2,875.80
  • 100 Day
  • ₹2,779.35
  • 200 Day
  • ₹2,708.62

Resistance and Support

3088.37 Pivot Speed
  • R3 3,391.73
  • R2 3,309.87
  • R1 3,170.23
  • S1 2,948.73
  • S2 2,866.87
  • S3 2,727.23

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ajanta Pharma is a specialty pharmaceutical company offering innovative, high-quality medicines across 30+ countries. With leadership in multiple therapeutic segments, Ajanta operates 7 state-of-the-art manufacturing facilities, supported by robust R&D capabilities and a strong global presence.

Ajanta Pharma has an operating revenue of Rs. 5,201.63 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 26% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 17% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 74 which is a FAIR score but needs to improve its earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 26 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ajanta Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-30 Quarterly Results
2025-11-03 Quarterly Results & Interim Dividend
2025-07-28 Quarterly Results & Others To consider other business matters. per share(475%)Interim Dividend
2025-04-30 Audited Results & A.G.M.
2025-01-30 Quarterly Results
Date Purpose Remarks
2025-11-10 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-11-06 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-02-08 INTERIM Rs.26.00 per share(1300%)Second Interim Dividend
2023-08-04 SPECIAL Rs.15.00 per share(750%)Special Dividend
2023-08-04 INTERIM Rs.10.00 per share(500%)First Interim Dividend
View Ajanta Pharma Dividend History Arrow
Date Purpose Remarks
2022-06-23 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma F&O

Ajanta Pharma Shareholding Pattern

66.25%
15.49%
2.65%
7.97%
0%
6.44%
1.2%

About Ajanta Pharma

  • NSE Symbol
  • AJANTPHARM
  • BSE Symbol
  • 532331
  • Managing Director
  • Mr. Yogesh M Agrawal
  • ISIN
  • INE031B01049

Similar Stocks to Ajanta Pharma

Ajanta Pharma FAQs

Ajanta Pharma share price is ₹3,030 As on 14 March, 2026 | 04:50

The Market Cap of Ajanta Pharma is ₹37855.9 Cr As on 14 March, 2026 | 04:50

The P/E ratio of Ajanta Pharma is 37.3 As on 14 March, 2026 | 04:50

The PB ratio of Ajanta Pharma is 8.2 As on 14 March, 2026 | 04:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23